Latest Biotech News

Iambic Therapeutics, an Nvidia-backed AI drug-discovery company, priced a $150 million initial public offering and is set to begin trading this week. The cancer-focused biotech sold 9.38 million...

OMass Therapeutics, an Oxford-based developer targeting genetic adrenal disorders, raised $310 million in a private financing. The company said it plans to pursue programs in endocrinology, taking...

Pfizer signed a research collaboration and licensing agreement with Enodia Therapeutics that gives the pharma a stake in Sec61 inhibition programs. Under the deal, Enodia will run discovery work...

The European Medicines Agency will make an EU-level trial advice pilot a permanent option for drug sponsors. In a regulatory update, EMA confirmed that sponsors running studies in the European...

A prospective controlled study in BMC Medicine reported that adding hepatic arterial infusion chemotherapy to lenvatinib and a PD-1 inhibitor roughly doubled median overall survival in advanced...

Arrowhead Pharmaceuticals reported early clinical results suggesting its brain-targeting RNA interference medicine can reduce tau protein levels in humans. In a trial in healthy volunteers, the...

Verastem Oncology reported new data across multiple tumor types for its KRAS-mutant program VS-7375 and simultaneously announced a leadership change and funding. The company said its experimental...

Researchers led by Radojka M. Savic and Véronique Dartois built a validated translational tool connecting how well anti-tuberculosis drugs penetrate lung lesions to the chance of success in...

Healthleap secured $38 million to scale its clinical AI platform that runs inside electronic health records. The company’s screening system targets conditions that may otherwise go undiagnosed in...

Two neuroscience-facing studies underscored how RNA regulation can reshape neurodegeneration pathways. A transcriptomic aging-screen identified SRSF1 as a conserved regulator of aging, with...

Iambic Therapeutics priced a $150 million IPO, starting trading Thursday after selling 9.38 million shares at $16 each. The cancer-focused company positions its AI-driven platform as a way to...

A new study suggests a hidden immune gene variant may help explain dangerous blood transfusion reactions in transfusion-dependent thalassemia patients. By linking immunologic recognition risk to...

Scientists reported that pig kidneys cooled to about -150°C and stored for months can be rewarmed and function again, with urine production after transplantation into pigs. The preprint describes...

The European Medicines Agency (EMA) confirmed it will turn an EU-level clinical trial advice pilot into a permanent option for sponsors. That change means companies can continue seeking harmonized...

A prospective Chinese study reported striking responses in locally advanced nasopharyngeal carcinoma when camrelizumab was added to induction chemotherapy before concurrent chemoradiotherapy....

Researchers mapped a USP11–IGF2BP2–ATOX1 molecular axis that shields non-small cell lung cancer cells from copper-driven cuproptosis. By identifying the pathway that preserves cell survival under...

A prospective controlled study reported that adding hepatic arterial infusion chemotherapy to lenvatinib plus a PD-1 inhibitor roughly doubled median overall survival in advanced liver cancer...

Arrowhead reported early human target-engagement support for a brain-shuttling delivery approach using systemic RNAi dosing in healthy volunteers. The company framed the milestone as progress on...

A multi-site clinical trial found pharmacist integration into primary care teams for opioid use disorder was feasible and acceptable, with modest improvements in treatment retention and adherence....

A randomized double-blind trial reported that sodium zirconium cyclosilicate helped more chronic kidney disease patients with heart failure reach target doses of life-prolonging RAAS inhibitors...